Meta-analysis on the medications’ common mechanism and immuno–gut microbiota interactions suggested AMPK pathway and macrophage as the regulators of gut microbiota in HBP patients taking antihypertension medication, and we verified such hypothesis by using macrophage-specific AMPK-knockout mouse hypertension model. This evidence concerns the gene PRKAA1 and hypertensive disorder.